These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 3011677
1. Western blot technique in the serological evaluation of three LAV/HTLV III-infected Italian families. Geroldi D, Aricò M, Plebani A, Maccario R, Notarangelo LD, Duse M, Rey F, Barrè Sinoussi F, Chermann JC, Burgio GR. Infection; 1986; 14(2):60-3. PubMed ID: 3011677 [Abstract] [Full Text] [Related]
2. [Anti-HTLV III/LAV antibodies of the IgM class in subjects at risk with negative anti-HTLV III/LAV IgG ELISA results (preliminary results)]. Bedarida G, D'Agostino F, Ronsivalle MG, Berto E, Cambiè G, Berto N, Grisi ME, Arcidiacono I, Sterza G. Riv Emoter Immunoematol; 1986; 33(1):75-87. PubMed ID: 3532290 [No Abstract] [Full Text] [Related]
3. Testing for antibodies to AIDS-associated retrovirus (HTLV-III/LAV) by indirect fixed cell immunofluorescence: specificity, sensitivity, and applications. Hedenskog M, Dewhurst S, Ludvigsen C, Sinangil F, Rodriguez L, Wu YT, Volsky DJ. J Med Virol; 1986 Aug; 19(4):325-34. PubMed ID: 3018138 [Abstract] [Full Text] [Related]
4. Antibodies to acquired immune deficiency syndrome (AIDS)-associated virus (HTLV-III/LAV) in Venezuelan populations. Volsky DJ, Rodriguez L, Dewhurst S, Sinangil F, Sakai K, Merino F, Esparza B, De Salvo L. AIDS Res; 1986 Aug; 2(2):79-92. PubMed ID: 3013223 [Abstract] [Full Text] [Related]
5. Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood. Esteban JI, Shih JW, Tai CC, Bodner AJ, Kay JW, Alter HJ. Lancet; 1985 Nov 16; 2(8464):1083-6. PubMed ID: 2865566 [Abstract] [Full Text] [Related]
8. Prevalence of HTLV-III/LAV in household contacts of patients with confirmed AIDS and controls in Kinshasa, Zaire. Mann JM, Quinn TC, Francis H, Nzilambi N, Bosenge N, Bila K, McCormick JB, Ruti K, Asila PK, Curran JW. JAMA; 1986 Aug 08; 256(6):721-4. PubMed ID: 3014178 [Abstract] [Full Text] [Related]
9. Evaluation of serological cross-reactivity between antibodies to Plasmodium and HTLV-III/LAV. Greenberg AE, Schable CA, Sulzer AJ, Collins WE, Phuc Nguyen-Dinh. Lancet; 1986 Aug 02; 2(8501):247-9. PubMed ID: 2874279 [Abstract] [Full Text] [Related]
10. HTLV-III/LAV infection in nine children infected by a single plasma donor: clinical outcome and recognition patterns of viral proteins. Lange JM, van den Berg H, Dooren LJ, Vossen JM, Kuis W, Goudsmit J. J Infect Dis; 1986 Jul 02; 154(1):171-4. PubMed ID: 3011923 [No Abstract] [Full Text] [Related]
15. Determination of antibodies against LAV/HTLV III: comparative evaluation of four different commercial test kits. Abb J. AIDS Res; 1986 May 02; 2(2):93-7. PubMed ID: 3013224 [Abstract] [Full Text] [Related]
16. An immunoglobulin G capture assay (GACRIA) for anti-HTLV III/LAV and its use as a confirmatory test. Parry JV. J Med Virol; 1986 Aug 02; 19(4):387-97. PubMed ID: 3018141 [Abstract] [Full Text] [Related]
17. Detection of human T-cell lymphotropic virus type III-related antigens and anti-human T-cell lymphotropic virus type III antibodies by anticomplementary immunofluorescence. Blumberg RS, Sandstrom EG, Paradis TJ, Neumeyer DN, Sarngadharan MG, Hartshorn KL, Byington RE, Hirsch MS, Schooley RT. J Clin Microbiol; 1986 Jun 02; 23(6):1072-7. PubMed ID: 2423552 [Abstract] [Full Text] [Related]
20. Spectrum of human T-cell lymphotropic virus type III infection in children. Recognition of symptomatic, asymptomatic, and seronegative patients. Pahwa S, Kaplan M, Fikrig S, Pahwa R, Sarngadharan MG, Popovic M, Gallo RC. JAMA; 1986 May 02; 255(17):2299-305. PubMed ID: 3007791 [Abstract] [Full Text] [Related] Page: [Next] [New Search]